• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重度抑郁症的阶段和行为多种共病:来自全国代表性流行病学研究的结果。

Stages of major depressive disorder and behavioral multi-morbidities: Findings from nationally representative epidemiologic study.

机构信息

Department of Public Health Sciences, School of Medicine, University of Connecticut, Farmington, CT, United States of America; Department of Psychiatry, School of Medicine, Yale University, New Haven, CT, United States of America; Mental Illness Research, Education and Clinical Center of New England, US Department of Veterans Affairs Connecticut Healthcare System, West Haven, CT, United States of America.

Department of Psychiatry, School of Medicine, Yale University, New Haven, CT, United States of America; Mental Illness Research, Education and Clinical Center of New England, US Department of Veterans Affairs Connecticut Healthcare System, West Haven, CT, United States of America.

出版信息

J Affect Disord. 2021 Jan 1;278:443-452. doi: 10.1016/j.jad.2020.09.081. Epub 2020 Sep 25.

DOI:10.1016/j.jad.2020.09.081
PMID:33010569
Abstract

OBJECTIVE

To present a three stage-model of major depressive disorder (MDD) and evaluate differences in behavioral histories/experiences and multi-morbidities between stages.

METHODS

We used data from the 2012-2013 National Epidemiologic Survey on Alcohol and Related Conditions-III, a nationally representative cross-sectional survey of US adults (n = 36,309). Based on DSM-5 diagnostic criteria, we identified and compared three groups of adults with MDD histories: 1) new onset MDD (n = 509; 5.6%); 2) chronic MDD (n = 3,871; 46.1%); and 3) recovered from MDD (n = 3,673; 48.3%). Multivariable analyses tested independent group differences in behavioral histories/experiences and diagnostic multi-morbidities between 1) recovered MDD vs. new onset MDD; 2) chronic MDD vs. new onset MDD; and 3) recovered MDD vs. chronic MDD.

RESULTS

Adults who have recovered from MDD as compared to those with chronic MDD were 2.5 times more likely to have recovered from two or more psychiatric disorders in addition to MDD (95% confidence intervals [CI]=1.76-3.61) and from alcohol use disorder (adjusted odds ratio [AOR]=1.28; 95% CI=1.08-1.52). They were also less likely than those with chronic MDD to have borderline personality disorder (p<0.001), pain (p<0.001), or medical co-morbidity (p = 0.003). Adults with new onset MDD were younger than other groups, and more likely than those who have recovered to have borderline personality disorder and concurrent psychiatric or substance use disorders (p<0.05 for all).

CONCLUSION

Behavioral histories/experiences and multi-morbidities differ significantly across stages of MDD. These concurrent problems may impede recovery and foster chronicity and should therefore be an integral focus of treatment.

摘要

目的

提出重性抑郁障碍(MDD)的三阶段模型,并评估各阶段之间行为史/经历和多种合并症的差异。

方法

我们使用了 2012-2013 年国家酒精相关情况和条件 III 流行病学调查的数据,这是一项对美国成年人的全国代表性横断面调查(n=36309)。根据 DSM-5 诊断标准,我们确定并比较了三组有 MDD 病史的成年人:1)新发 MDD(n=509;5.6%);2)慢性 MDD(n=3871;46.1%);3)MDD 缓解(n=3673;48.3%)。多变量分析检验了 1)缓解 MDD 与新发 MDD 之间;2)慢性 MDD 与新发 MDD 之间;3)缓解 MDD 与慢性 MDD 之间,行为史/经历和诊断合并症的独立组间差异。

结果

与慢性 MDD 相比,缓解 MDD 的成年人除 MDD 之外,还有两倍以上的可能性从两种或多种精神障碍和酒精使用障碍中康复(95%置信区间[CI]=1.76-3.61)和酒精使用障碍(调整后的优势比[AOR]=1.28;95%CI=1.08-1.52)。与慢性 MDD 相比,他们也更不可能患有边缘型人格障碍(p<0.001)、疼痛(p<0.001)或合并医学疾病(p=0.003)。新发 MDD 的成年人比其他组更年轻,与缓解组相比,更有可能患有边缘型人格障碍和并发精神或物质使用障碍(p<0.05)。

结论

MDD 各阶段之间的行为史/经历和多种合并症存在显著差异。这些并存问题可能会阻碍康复,促进慢性化,因此应成为治疗的重点。

相似文献

1
Stages of major depressive disorder and behavioral multi-morbidities: Findings from nationally representative epidemiologic study.重度抑郁症的阶段和行为多种共病:来自全国代表性流行病学研究的结果。
J Affect Disord. 2021 Jan 1;278:443-452. doi: 10.1016/j.jad.2020.09.081. Epub 2020 Sep 25.
2
Epidemiology of Adult DSM-5 Major Depressive Disorder and Its Specifiers in the United States.美国成人 DSM-5 重性抑郁障碍及其特征的流行病学。
JAMA Psychiatry. 2018 Apr 1;75(4):336-346. doi: 10.1001/jamapsychiatry.2017.4602.
3
Major depressive disorder in vulnerable groups of older adults, their course and treatment, and psychiatric comorbidity.老年人群中易患抑郁症患者的主要问题、病程和治疗以及精神共病问题。
Depress Anxiety. 2013 Jun;30(6):528-37. doi: 10.1002/da.22073. Epub 2013 Feb 19.
4
Differences among major depressive disorder with and without co-occurring substance use disorders and substance-induced depressive disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions.主要抑郁障碍伴或不伴物质使用障碍及物质所致抑郁障碍的差异:来自国家酒精相关条件流行病学调查的结果。
J Clin Psychiatry. 2012 Jun;73(6):865-73. doi: 10.4088/JCP.10m06673. Epub 2012 Mar 20.
5
Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions.重度抑郁症的流行病学:全国酒精中毒及相关疾病流行病学调查结果
Arch Gen Psychiatry. 2005 Oct;62(10):1097-106. doi: 10.1001/archpsyc.62.10.1097.
6
Major depressive disorder and impaired health-related quality of life among US older adults.美国老年人的重度抑郁症与健康相关生活质量受损。
Int J Geriatr Psychiatry. 2020 Oct;35(10):1189-1197. doi: 10.1002/gps.5356. Epub 2020 Jul 19.
7
Exploring the correlates of suicide attempts among individuals with major depressive disorder: findings from the national epidemiologic survey on alcohol and related conditions.探究重度抑郁症患者自杀未遂的相关因素:来自酒精及相关状况全国流行病学调查的结果
J Clin Psychiatry. 2008 Jul;69(7):1139-49. doi: 10.4088/jcp.v69n0714.
8
Comorbidity of depressive and anxiety disorders for older Americans in the national comorbidity survey-replication.《全国共病调查复制版》中美国老年人抑郁障碍与焦虑障碍的共病情况
Am J Geriatr Psychiatry. 2009 Sep;17(9):782-92. doi: 10.1097/JGP.0b013e3181ad4d17.
9
Subsyndromal depression among older adults in the USA: prevalence, comorbidity, and risk for new-onset psychiatric disorders in late life.美国老年人中的亚综合征性抑郁:患病率、共病情况及晚年新发精神障碍的风险
Int J Geriatr Psychiatry. 2015 Jul;30(7):677-85. doi: 10.1002/gps.4204. Epub 2014 Oct 23.
10
Epidemiology of chronic and nonchronic major depressive disorder: results from the national epidemiologic survey on alcohol and related conditions.慢性和非慢性重度抑郁症的流行病学:来自全国酒精和相关条件的流行病学调查。
Depress Anxiety. 2011 Aug;28(8):622-31. doi: 10.1002/da.20864.

引用本文的文献

1
Exploring psychotherapists' experiences in delivering effective treatment for major depression in Saudi Arabia: a qualitative study.探索沙特阿拉伯心理治疗师提供重度抑郁症有效治疗的经验:一项定性研究。
Sci Rep. 2025 Jul 16;15(1):25862. doi: 10.1038/s41598-025-11293-3.
2
The progress in the field of clinical staging for mental disorders within the last decade: an updated systematic review.过去十年精神障碍临床分期领域的进展:一项更新的系统评价
Front Psychiatry. 2025 Jan 15;15:1473051. doi: 10.3389/fpsyt.2024.1473051. eCollection 2024.
3
Neuropsychological Assessments of Cognitive Impairment in Major Depressive Disorder: A Systematic Review and Meta-Analysis with Meta-Regression.
重度抑郁症认知障碍的神经心理学评估:系统评价和荟萃分析及荟萃回归。
Psychother Psychosom. 2024;93(1):8-23. doi: 10.1159/000535665. Epub 2024 Jan 25.
4
Efficacy and safety of ketamine-assisted electroconvulsive therapy in major depressive episode: a systematic review and network meta-analysis.氯胺酮辅助电抽搐治疗在重度抑郁发作中的疗效和安全性:系统评价和网络荟萃分析。
Mol Psychiatry. 2024 Mar;29(3):750-759. doi: 10.1038/s41380-023-02366-8. Epub 2023 Dec 20.
5
Identification of potential Mitogen-Activated Protein Kinase-related key genes and regulation networks in molecular subtypes of major depressive disorder.重度抑郁症分子亚型中潜在的丝裂原活化蛋白激酶相关关键基因及调控网络的鉴定
Front Psychiatry. 2022 Oct 21;13:1004945. doi: 10.3389/fpsyt.2022.1004945. eCollection 2022.
6
Comorbid Chronic Pain and Depression: Shared Risk Factors and Differential Antidepressant Effectiveness.共病慢性疼痛与抑郁症:共同风险因素及抗抑郁药疗效差异
Front Psychiatry. 2021 Apr 12;12:643609. doi: 10.3389/fpsyt.2021.643609. eCollection 2021.